2 Top Space Stocks I Like Better Than SpaceX

Rocket Lab’s planned Neutron rocket could lift payload capacity from 300 kg to 13,000 kg, potentially improving unit economics, but the stock trades at a lofty 70x sales with execution risk around launch timing. Intuitive Machines is supported by a $180 million NASA contract and a $235.9 million backlog, though fourth-quarter revenue fell 11.5% year over year to $58.5 million and the business remains speculative. The article is primarily comparative commentary on small-cap space names rather than new company-specific catalyst news.

Analysis

The real second-order read-through is that the competitive moat in this space is shifting from pure launch cadence to capital intensity and contract credibility. If larger rockets like Neutron work on schedule, Rocket Lab can move up the value chain into fewer, higher-margin, lower-frequency missions, which should compress customer concentration risk and increase pricing power. But that transition also raises execution sensitivity: one meaningful delay can keep it trapped in the small-launch bucket while fixed costs ramp, which is typically when the market de-rates these names hardest.

Intuitive Machines is a different animal: it is less a broad space-growth proxy than a government procurement lever. The backstop is not end-demand growth but NASA's willingness to outsource more lunar logistics; that can create a multi-year revenue ladder if missions remain reliable, but it also means contract timing and mission success matter more than topline momentum. The key asymmetry is that the stock can rerate on backlog conversion even before profitability arrives, yet any mission failure would likely reset confidence across the entire CLPS ecosystem.

The market is likely underappreciating how much of the implied upside in both names is already contingent on flawless execution. For RKLB, the valuation bakes in a near-term Neutron success and meaningful scale benefits before those benefits are proven; for LUNR, the stock is more defensible if you view it as a recurring government services compounder rather than a speculative moonshot. Consensus seems to be treating both as "space beneficiaries," but the fundamentals diverge sharply: RKLB is an industrial scaling story, LUNR is a procurement/optionality story.

A broader implication: if SpaceX eventually lists, it may crowd out some retail enthusiasm for adjacent public names, but that could also be a clearing event that separates real operating leverage from narrative-driven multiples. The cleaner trade is to own the company with visible backlog-to-revenue conversion and avoid paying peak enthusiasm for the one still waiting on its most important product launch.

Key Decisions for Investors

• Long LUNR on pullbacks over the next 2-6 weeks: favor a starter position only after market digests the latest NASA contract; upside is backlog conversion and multiple expansion, but size small because mission/contract headline risk can gap the stock 15-25% intraday.
• Avoid chasing RKLB until Neutron timing is de-risked: the risk/reward is poor above current enthusiasm because any launch delay could compress the multiple faster than new data can support it; wait for a post-catalyst entry or use a staggered buy only if launch milestones are confirmed.
• Pair trade: long LUNR / short RKLB for 1-3 months if you want space exposure with lower execution beta; LUNR has clearer government-backed revenue visibility while RKLB carries higher binary launch risk and a richer expectation base.
• For more aggressive accounts, buy LUNR call spreads into contract/mission catalysts rather than stock: defined risk works better here because upside is driven by discrete rerating events, while downside is dominated by headline volatility.
• Do not buy both as a basket expecting simple thematic beta; the better allocation is one unit of "government procurement visibility" (LUNR) or one unit of "manufacturing scale optionality" (RKLB), not both at full size.